Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring
A Mayo Clinic-sponsored clinical trial aiming to optimize treatment for stage IV/metastatic breast cancer through real-time disease monitori…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test [Phase 1, Phase 2]
A Phase Ib/II trial evaluating neratinib plus capmatinib in metastatic breast cancer and inflammatory breast cancer with abnormal HER-family…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Moving Forward Together 4 [NA]
An update on the ongoing clinical trial 'Moving Forward Together 4' sponsored by the University of South Carolina; the study is currently ac…
-
FDA approval · 2025-05-14FDA Approved: KADCYLA — Supplemental Application (Genentech, Inc.)
A supplemental application for KADCYLA (ado-trastuzumab emtansine) submitted to the FDA by Genentech, Inc.
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection
A Ain Shams University-sponsored clinical trial is evaluating whether a modified abbreviated protocol using ultra-high B-value diffusion-wei…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Brodalumab in the Treatment of Immune-Related Adverse Events [Phase 1]
Phase 1 study of brodalumab for treatment of immune-related adverse events in cancer patients. The trial is currently recruiting across mult…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating Mecapegfilgrastim to prevent neutropenia induced by dalpiciclib in metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy [Phase 3]
This Phase 3 safety study investigates adding Everolimus to adjuvant hormone therapy in women with ER-positive, HER2-negative primary breast…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
A clinical trial evaluating pembrolizumab with neoadjuvant chemo-immunotherapy for early-stage triple-negative breast cancer is currently re…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Brain Imaging, Nutrition, and Cognition in Breast Cancer Survivors
The Ohio State University–led trial evaluating brain imaging, nutrition, and cognition in breast cancer survivors has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Definitive Radiation for High-Risk Spine Metastases [Phase 2]
A Phase 2 clinical trial evaluating definitive radiation therapy for high-risk spine metastases is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Standard or Hypofractionated Radiotherapy Versus Accelerated Partial Breast Irradiation (APBI) for Breast Cancer [NA]
This update concerns a trial comparing standard or hypofractionated radiotherapy with accelerated partial breast irradiation for breast canc…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies
This entry describes a long-term follow-up study of patients with early-stage invasive breast cancer enrolled in GEICAM trials, which is cur…
-
EMA approval · 2025-05-13EMA Authorised: Kanjinti (trastuzumab) — Amgen Europe B.V.
The European Medicines Agency authorised Kanjinti (trastuzumab) by Amgen Europe B.V. for gastric and breast cancers.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: A Study of A166 Versus Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane Therapy [Phase 3]
Phase 3 study comparing A166 to Trastuzumab Emtansine (T-DM1) in HER2-positive unresectable or metastatic breast cancer; the trial is curren…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer [Phase 1, Phase 2]
Clinical trial update indicating a Phase 1/Phase 2 study of ribociclib, tucatinib, and trastuzumab for HER2-positive breast cancer is curren…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Brain Health in Breast Cancer Survivors
A Jonsson Comprehensive Cancer Center study is currently recruiting to evaluate brain health and cognitive function in breast cancer survivo…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Yoga for Symptoms of Nerve Damage Caused by Chemotherapy [NA]
The document reports a completed clinical trial evaluating yoga to reduce chemotherapy-induced nerve damage (peripheral neuropathy) in patie…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Early Ageing During Therapy in AYA Cancer Patients
A clinical trial investigating early ageing during therapy in adolescents and young adults with cancer is currently recruiting. The study co…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer [Phase 3]
A Phase 3 feasibility trial of Tele-IPT and tele-pharmacotherapy for patients with Major Depressive Disorder and non-metastatic breast cance…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Hypofractionated PBI After BCS for Low-risk Breast Cancer Patients [NA]
The trial from Fudan University evaluating hypofractionated partial-breast irradiation after breast-conserving surgery for low-risk breast c…
-
FDA approval · 2025-05-13FDA Approved: DOCETAXEL — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approves a generic docetaxel product under an original ANDA for Meitheal Pharmaceuticals Inc.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Patient Education Strategy for Breast Cancer Patients During Perioperative Hospitalization Stage [NA]
A clinical trial from Fudan University explores a patient education strategy for breast cancer patients during perioperative hospitalization…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: A Real World Study of Sacituzumab Govitecan
Real-world study evaluating Sacituzumab Govitecan for metastatic breast cancer is currently recruiting at Fudan University.
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors [Phase 1]
DS-1103a combination therapy is being studied in a Phase 1 trial for participants with advanced solid tumors and breast cancer; the study is…